Study Status: Active, not recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Photodynamic Therapy For Childhood Brain Tumors, A Phase I Study
Brief Summary:
RATIONALE: Photodynamic therapy uses light and photosensitizing drugs to kill tumor cells and may be an effective treatment for refractory brain tumors.
PURPOSE: This phase I trial is studying the side effects and best dose of photodynamic therapy using porfimer sodium in treating patients with refractory brain tumors, including astrocytoma, ependymoma, and medulloblastoma.